Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori
Open Access
- 15 July 2021
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 15 (4), 528-536
- https://doi.org/10.5009/gnl20225
Abstract
Sang Yoon Kim, Jae Myung Park, Chul-Hyun Lim, Hye Ah Lee, Ga-Yeong Shin, Younghee Choe, Yu Kyung Cho, and Myung-Gyu Choi. Gut and Liver 2021;15:528-36. https://doi.org/10.5009/gnl20225Keywords
This publication has 42 references indexed in Scilit:
- Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin ResistanceThe Journal of Infectious Diseases, 2013
- Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012Helicobacter, 2012
- DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycinBMC Gastroenterology, 2011
- Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in JapanJournal of Gastroenterology and Hepatology, 2011
- Clarithromycin-Resistant Genotypes and Eradication of Helicobacter PyloriThe Journal of Pediatrics, 2010
- Helicobacter pylori treatment in the era of increasing antibiotic resistanceGut, 2010
- Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance inHelicobacter pyloriJournal of Clinical Microbiology, 2009
- Dual‐Priming Oligonucleotide‐Based Multiplex PCR for the Detection of Helicobacter pylori and Determination of Clarithromycin Resistance with Gastric Biopsy SpecimensHelicobacter, 2009
- Helicobacter pyloriDetection and Antimicrobial Susceptibility TestingClinical Microbiology Reviews, 2007
- H pylori antibiotic resistance: prevalence, importance, and advances in testingGut, 2004